Markers of Atherosclerosis in Hypertensive Patients with Less Advanced Chronic Kidney Disease

1. Fest J, Ruiter R, Ikram MA, Voortman T, van Eijck CHJ, Stricker BH. Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study. Sci Rep. 2018;8(1):10566.10.1038/s41598-018-28646-w604360930002404Search in Google Scholar

2. Stenvinkel P. Inflammation in end-stage renal disease--a fire that burns within. Contrib Nephrol. 2005;149:185-99.10.1159/00008552515876843Search in Google Scholar

3. Navarro JF, Milena FJ, Mora C, León C, García J. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol. 2006;26(6):562–70.10.1159/00009800417167242Search in Google Scholar

4. Fogo AB. Mechanisms of progression of chronic kidney disease. Pediatr Nephrol. 2007;22(12):2011–22.10.1007/s00467-007-0524-0206494217647026Search in Google Scholar

5. Snaedal S, Heimbürger O, Qureshi AR, et al. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Am J Kidney Dis. 2009;53(6):1024-33.10.1053/j.ajkd.2009.02.00819394732Search in Google Scholar

6. Turkmen K, Guney I, Yerlikaya FH, Tonbul HZ. The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren Fail. 2012;34(2):155–9.10.3109/0886022X.2011.64151422172001Search in Google Scholar

7. Valente MJ, Rocha S, Coimbra S et al. Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality. Mediators Inflamm. 2019;3295725.10.1155/2019/3295725660429431316299Search in Google Scholar

8. Krzanowski M, Krzanowska K, Gajda M, et al. Pentraxin 3 as a new indicator of cardiovascular-related death in patients with advanced chronic kidney disease. Pol Arch Intern Med. 2017;127(3):170-7.10.20452/pamw.3944Search in Google Scholar

9. Forget P, Khalifa C, Defour JP, et al. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10(1):12.10.1186/s13104-016-2335-5521725628057051Search in Google Scholar

10. Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124.10.1093/jnci/dju12424875653Search in Google Scholar

11. Fest J, Ruiter TR, Groot Koerkamp B, et al. The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: The Rotterdam Study. Eur J Epidemiol. 2019;34(5):463-79.10.1007/s10654-018-0472-y645646930569368Search in Google Scholar

12. Christiansen MH, Barup KØ, Samson MH. Neutrophil-lymphocyte-ratio distributions in a Danish population from general practice. Scand J Clin Lab Invest. 2019;79(1-2):75-7910.1080/00365513.2018.155585630638080Search in Google Scholar

13. Huguet E, Maccallini G, Pardini P, et al. Reference Values for Neutrophil to Lymphocyte Ratio (NLR), a Biomarker of Cardiovascular Risk, According to Age and Sex in a Latin American Population. Curr Probl Cardiol. 2019. pii: S0146-2806(19)30054-4.Search in Google Scholar

14. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045-51.10.1161/ATVBAHA.108.179705342275422895665Search in Google Scholar

15. Corriere T, Di Marca S, Cataudella E et al. Neutrophil-to-Lymphocyte Ratio is a strong predictor of atherosclerotic carotid plaques in older adults. Nutr Metab Cardiovasc Dis. 2018;28(1):23-7.10.1016/j.numecd.2017.10.02229241668Search in Google Scholar

16. Verdoia M, Barbieri L, Di Giovine G et al. Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results From a Large Cohort Study. Angiology. 2016;67(1):75-82.10.1177/000331971557752925818102Search in Google Scholar

17. Zhou S, Cai B, Zhang Y, Wang L, Liu X, Xu G. The Relationship between Neutrophil-to-Lymphocyte Ratio and Aortic Arch Calcification in Ischemic Stroke Patients. J Stroke Cerebrovasc Dis. 2017;26(6):1228-32.10.1016/j.jstrokecerebrovasdis.2017.01.01228162903Search in Google Scholar

18. Yoshitomi R, Nakayama M, Sakoh T et al. High neutrophil/lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease. Ren Fail. 2019;41(1):238-43.10.1080/0886022X.2019.1595645645058230942116Search in Google Scholar

19. Yuan Q, Wang J, Peng Z et al. Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE). J Transl Med. 2019;17(1):86.10.1186/s12967-019-1808-4642074630876475Search in Google Scholar

20. Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: The killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009;20(7):1453-64.10.1681/ASN.200807069219478096Search in Google Scholar

21. London GM, Guerin AP, Marchais S, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731–40.10.1093/ndt/gfg41412937218Search in Google Scholar

22. Neuen BL, Leather N, Greenwood AM, Gunnarsson R, Cho Y, Mantha ML. Neutrophil-lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients. Ren Fail. 2016;38(1):70-6.10.3109/0886022X.2015.110499026540580Search in Google Scholar

23. Iijima K, Hashimoto H, Hashimoto M et al. Aortic arch calcification detectable on chest X-ray is a strong independent predictor of cardiovascular events beyond traditional risk factors. Atherosclerosis. 2010;210(1):137-44.10.1016/j.atherosclerosis.2009.11.01220006335Search in Google Scholar

24. Inoue T, Ogawa T, Ishida H, Ando Y, Nitta K. Aortic arch calcification evaluated on chest X-ray is a strong independent predictor of cardiovascular events in chronic hemodialysis patients. Heart Vessels. 2012;27(2):135-42.10.1007/s00380-011-0129-121416116Search in Google Scholar

25. Kalra SS, Shanahan CM. Vascular calcification and hypertension: cause and effect. Ann Med. 2012;44 Suppl 1:S85-92.10.3109/07853890.2012.66049822713153Search in Google Scholar

26. Zhou S, Cai B, Zhang Y, Wang L, Liu X, Xu G. The Relationship between Neutrophil-to-Lymphocyte Ratio and Aortic Arch Calcification in Ischemic Stroke Patients. J Stroke Cerebrovasc Dis. 2017;26(6):1228-32.10.1016/j.jstrokecerebrovasdis.2017.01.01228162903Search in Google Scholar

27. Turkmen K, Ozcicek F, Ozcicek A, Akbas EM, Erdur FM, Tonbul HZ. The relationship between neutrophil-to-lymphocyte ratio and vascular calcification in end-stage renal disease patients. Hemodial Int. 2014;18(1):47-53.10.1111/hdi.1206523819627Search in Google Scholar

28. Cai K, Luo Q, Zhu B, et al. Neutrophil-lymphocyte ratio is associated with arterial stiffness in patients with peritoneal dialysis. BMC Nephrol. 2016;17(1):191.10.1186/s12882-016-0394-4512214827881094Search in Google Scholar

29. Guo J, Fujiyoshi A, Willcox B et al. Increased Aortic Calcification Is Associated With Arterial Stiffness Progression in Multiethnic Middle-Aged Men. Hypertension. 2017;69(1):102-8.10.1161/HYPERTENSIONAHA.116.08459514572727821619Search in Google Scholar

30. Odink AE, Mattace-Raso FU, van der Lugt A et al. The association of arterial stiffness and arterial calcification: the Rotterdam study. J Hum Hypertens. 2008;22(3):205-7.10.1038/sj.jhh.100231518172454Search in Google Scholar

31. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1)1–150.Search in Google Scholar

32. Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041.10.1097/HJH.000000000000194030234752Search in Google Scholar

33. Symeonidis G, Papanas N, Giannakis I et al. Gravity of aortic arch calcification as evaluated in adult Greek patients. Int Angiol. 2002;21:233-6.Search in Google Scholar

34. Task Force Members, Montalescot G, Sechtem U, Achenbach S et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949-3003.10.1093/eurheartj/eht29623996286Search in Google Scholar

35. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO), The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763–816.10.1093/eurheartj/ehx095Search in Google Scholar

36. Yu HT. Progression of chronic renal failure. Arch Intern Med. 2003;163:1417–29.10.1001/archinte.163.12.1417Search in Google Scholar

37. Jacobson HR. Chronic renal failure: pathophysiology. Lancet. 1991. 338(8764):419–23.10.1016/0140-6736(91)91042-SSearch in Google Scholar

38. Swaminathan S, Shah SV. Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease. Kidney Int. 2011;80(5):453-63.10.1038/ki.2011.17821697810Search in Google Scholar

39. Subbiah AK, Chhabra YK, Mahajan S. Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup. Heart Asia. 2016;8(2):56–61.10.1136/heartasia-2016-010809513339527933104Search in Google Scholar

40. Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39(1-3):84-92.10.1159/00036894025662331Search in Google Scholar